Latest News for: target clinic

Edit

Alys Pharmaceuticals Announces Dosing of First Patient in Phase IIa Trial of ALY-101 for Alopecia Areata

Pharmiweb 27 Mar 2025
ALY-101 has been designed for precise target specificity, stability, enhanced skin affinity, and long-lasting clinical efficacy while minimizing systemic exposure, which is critical for safety across a broad range of clinical indications.”.
Edit

Spinal Muscular Atrophy Clinical Trials 2025: EMA, PDMA, FDA Approvals, Medication, Treatment Market, NDA Approval, ...

GetNews 27 Mar 2025
Food and Drug Administration (FDA) has accepted its Biologics License Application (BLA) for apitegromab, an investigational muscle-targeted treatment that is being developed to provide clinically ...
Edit

Challenging journey for eradicating Tuberculosis in Indonesia

Antara News 27 Mar 2025
Currently, 1,800 people in Indonesia have taken part in this clinical trial, with a target of two thousand participants in the "TB M72 Vaccine" clinical trial ... In fact, the success target is 90 percent for TBSO and 80 percent for TBRO.
Edit

Ulcerative Colitis Treatment Market 2034: EMA, PDMA, FDA Approvals, Clinical trials, Medication, Therapies, Prevalence and ...

GetNews 27 Mar 2025
According to DelveInsight analysis, the Ulcerative Colitis market is expected to rise in the coming years due to the entry of novel therapies with better clinical profile and patient convenient RoA, ...
Edit

Jaguar Health Meeting with FDA Regarding Results of Phase 3 OnTarget Study

ACCESSWIRE 27 Mar 2025
... 287 participants in this unprecedented prophylactic clinical trial recently conducted by Napo for diarrhea in adults with solid tumors receiving targeted therapy with or without standard chemotherapy.
Edit

TDH confirms state’s first measles case

The Nashville Ledger 27 Mar 2025
... top 5% of hospitals nationwide for overall clinical excellence ... Insights from the AGD database are being leveraged to accelerate drug target discovery, therapeutic research and clinical development.
Edit

InteliChart Named #1 End-to-End Patient Engagement Solution for Third Consecutive Year in Black Book(TM) 2025 Survey

ACCESSWIRE 27 Mar 2025
... performance metrics, offering more targeted and meaningful assessments in areas such as interoperability, automation, patient usability, platform scalability, and clinical communication outcomes.
Edit

New US airstrike campaign targeting Yemen's Houthi rebels more intense than last, AP review finds

Times Union 27 Mar 2025
Trump is targeting urban areas more intensely, judging from the number of strikes on cities so far ... They've claimed two attacks targeted an under-construction cancer clinic in the city of Saada, as well as private homes and crowded city neighborhoods.
Edit

New US airstrike campaign targeting Yemen’s Houthi rebels more intense than last, AP review finds

Chicago Tribune 27 Mar 2025
Trump is targeting urban areas more intensely, judging from the number of strikes on cities so far ... They’ve claimed two attacks targeted an under-construction cancer clinic in the city of Saada, as well as private homes and crowded city neighborhoods.
Edit

Uni-Bio Science Group Limited Announces 2024 Annual Results

Vietnam News 27 Mar 2025
1 ... Through this collaboration, we seek to establish a comprehensive ecological industry chain, spanning from target discovery to antibody generation, druggability verification, process development, clinical pipeline, and ultimately, commercialization.
Edit

Nouscom to Present Final Results from Successful Phase Ib/II Trial of NOUS-209 in People Living with Lynch Syndrome, Demonstrating Powerful Potential to Intercept Cancer in its Earliest Stages of Development

Pharmiweb 26 Mar 2025
Nouscom is a clinical-stage biotech company pioneering next-generation neoantigen-targeted immunotherapies to treat cancer at all stages, from early cancer interception to late stage metastatic disease.
Edit

Compugen to Participate in Multiple Virtual Investor Conferences in April 2025

Victoria Advocate 26 Mar 2025
CGEN) a clinical-stage cancer immunotherapy company and a ...
Edit

Acumen Pharmaceuticals Completes Enrollment of ALTITUDE-AD, a Phase 2 Clinical Trial of

Hastings Tribune 26 Mar 2025
ABOS), a clinical-stage biopharmaceutical company developing ...
×